<?xml version="1.0" encoding="UTF-8"?> 
		<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
		  <channel>
		    <image>
			<title>patentstorm.us</title>
			<width>258</width>
			<height>85</height>
			<link>http://www.patentstorm.us/</link>
			<url>http://www.patentstorm.us/images/logo.gif</url>
			</image>		

		    <title>PatentStorm -> Patents -> Organic compounds -- part of the class 532-570 series</title>
		    <link>http://www.patentstorm.us/rss/class/patents/rss-548.xml</link>
		    <description>Recent patents filings in USPTO Class 548 Organic compounds -- part of the class 532-570 series.</description>
		    <pubDate>Tue, 7 Feb 2012 16:03:19</pubDate>
		    <managingEditor>patents@patentstorm.us</managingEditor>
		    <language>en</language><item>
			         <title><![CDATA[Substituted indolocarbazoles]]></title>
			         <link>http://www.patentstorm.us/patents/8110690/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8110690</li><li><strong>Publication Date:</strong> &nbsp;2012-02-07</li><li><strong>Inventors:</strong> &nbsp;Ong, Beng S; Wu, Yiliang; Qi, Yu; Li, Yuning</li></ul>
<p>A substituted indolocarbazole comprising at least one optionally substituted ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8110690</guid>
			
			      </item>
<item>
			         <title><![CDATA[Pharmaceutical compounds]]></title>
			         <link>http://www.patentstorm.us/patents/8106218/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106218</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Lazzari, Paolo; Murineddu, Gabriele; Ruiu, Stefania; Pinna, Gerard Aime</li></ul>
<p>Tricyclic pyrazole derivatives of the following formula (I) having affinity for the cannabinoidergic CB1 and/or CB2 receptors:</p>
<p><chemistry>

</chemistry>
<br></br>
wherein:
<ul>
    <li>
    <ul>
        <li>A represents a group selected from one of the following: (CH<sub>2</sub>)<sub>t</sub>—, —(CH<sub>2</sub>)—S(O)<sub>z</sub>—, or —S(O)<sub>z</sub>—(CH<sub>2</sub>)—,</li>
        <li>B is a heteroaryl, optionally substituted;</li>
        <li>R is a group selected ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106218</guid>
			
			      </item>
<item>
			         <title><![CDATA[Ionic liquids with bis[bis(pentafluoroalkyl)phosphinyl]imides]]></title>
			         <link>http://www.patentstorm.us/patents/8106217/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106217</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Bissky, German; Heckmeier, Michael; Welz-Biermann, Urs; Ignatyev, Nikolai (Mykola); Willner, Helge</li></ul>
<p>The present invention relates to ionic liquids of low viscosity and high electrochemical stability, in particular for use in the area of electrochemistry and as solvents for carrying out chemical ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106217</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for the preparation of Irbesartan]]></title>
			         <link>http://www.patentstorm.us/patents/8106216/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106216</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Dandala, Ramesh; Meenakshisunderam, Sivakumaran; Korrapati, Venkata vara prasada rao; Inti, Venkata subramanyeswara rao; Ananta, Rani</li></ul>
<p>The present invention relates to an improved process for the preparation of 2-n-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]-1,3-diazaspiro[4.4]non-<b>1</b>-en-4-one ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106216</guid>
			
			      </item>
<item>
			         <title><![CDATA[3-aza-bicyclo[3.3.0]octane compounds]]></title>
			         <link>http://www.patentstorm.us/patents/8106215/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106215</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Aissaoui, Hamed; Boss, Christoph; Gude, Markus; Koberstein, Ralf; Sifferlen, Thierry</li></ul>
<p>The invention relates to 3-aza-bicyclo[3.3.0]octane derivatives of the formula (I) wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, and A are as described in the description and their use as orexin receptor ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106215</guid>
			
			      </item>
<item>
			         <title><![CDATA[2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors]]></title>
			         <link>http://www.patentstorm.us/patents/8106214/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106214</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Covini, David; Church, Dennis; Shaw, Jeffrey; Rueckle, Thomas</li></ul>
<p>The present invention is related to 2-imino-azolinone-vinyl fused-benzene derivatives of Formula (1) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106214</guid>
			
			      </item>
<item>
			         <title><![CDATA[Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them]]></title>
			         <link>http://www.patentstorm.us/patents/8106213/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8106213</li><li><strong>Publication Date:</strong> &nbsp;2012-01-31</li><li><strong>Inventors:</strong> &nbsp;Schindler, Ursula; Schönafinger, Karl; Strobel, Hartmut</li></ul>
<p>The present invention relates to compounds of the formula I</p>
<p><chemistry>

</chemistry>
<br></br>
wherein A<sup>1</sup>, A<sup>2</sup>, R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, X and n are as defined in the claims, which are valuable pharmaceutically active compounds for the therapy and prophylaxis of diseases, for example of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis. The compounds of the formula I are ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8106213</guid>
			
			      </item>
<item>
			         <title><![CDATA[Process for the preparation of highly optical pure carvedilol]]></title>
			         <link>http://www.patentstorm.us/patents/8101781/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101781</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Kim, Seong-Jin; Jong, Chang Woo; Kang, Hyun Bin; Moon, Byung Hyun; Quan, Long Guo; Won, Duk Kwon; Jin, Kyung Yong</li></ul>
<p>The present invention relates to a process for the efficient preparation of highly optical pure chiral carvedilol. According to the present invention, a chiral oxazolidin-2-one or oxazolidin-2-thione having formula 2, produced from the reaction of N-protected 2-(2-methoxyphenoxy)ethylamine with a chiral glycidol derivative is used as a key intermediate for the preparation of the chiral carvedilol. Specifically, the process for the preparation of the chiral carvedilol comprises a) reacting a ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101781</guid>
			
			      </item>
<item>
			         <title><![CDATA[Crystalline form of 3-(difluormethyl)-1-methyl-N-(3′,4′,5′-trifluor[1,1′-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide]]></title>
			         <link>http://www.patentstorm.us/patents/8101780/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101780</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Dieleman, Cedric; Smidt, Sebastian Peer; Saxell, Heidi Emilia; Dietz, Jochen</li></ul>
<p>The present invention relates to a new crystalline form of 3-(Difluormethyl)-1-methyl-N-(3′,4′,5′-trifluor[1,1′-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide. The invention also relates to processes for the production of this crystalline form and formulations for plant protection which contain the crystalline form of ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101780</guid>
			
			      </item>
<item>
			         <title><![CDATA[Enantioselective synthesis of (+) and (–)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene]]></title>
			         <link>http://www.patentstorm.us/patents/8101779/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101779</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Crooks, Peter A.; Vartak, Ashish Pramod</li></ul>
<p>Methods for the enantioselective synthesis of (+) and (−) lofexidine or 2-[1-(2,6)-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene involve converting (+) or (−) 1-methyl-1-[2,6-dichlorophenoxy]ethanamide to an (+) or (−) imino-ether intermediate by electrophilic attack of the amide oxygen by a trimethoxonium ion and, without isolation, converting the (+) or (−) imino-ether intermediate to (+) or (−) 2-[1-(2,6-dichlorophenoxy)-ethyl]1,3-diazacyclopent-2-ene by adding ethylene ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101779</guid>
			
			      </item>
<item>
			         <title><![CDATA[Five-membered heterocycles useful as serine protease inhibitors]]></title>
			         <link>http://www.patentstorm.us/patents/8101778/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101778</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Cavallaro, Cullen L.; Sun, Zhong; Hangeland, Jon J.; Corte, James R.; Smallheer, Joanne M.; Quan, Mimi L.; Bisacchi, Gregory S.; Friends, Todd J.; Rossi, Karen A.</li></ul>
<p>The present invention provides a method for treating a thrombotic or an inflammatory disorder administering to a patient in need thereof a therapeutically effective amount of at least one compound of Formula (I) or Formula (V):</p>
<p><chemistry>

</chemistry>
<br></br>
or a stereoisomer or pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L, Z, R<sup>3</sup>, R<sup>4</sup>, R<sup>6</sup>, R<sup>11</sup>, X<sup>1</sup>, X<sup>2</sup>, and X<sup>3 </sup>are ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101778</guid>
			
			      </item>
<item>
			         <title><![CDATA[Ionic liquids based on imidazolium salts incorporating a nitrile functionality]]></title>
			         <link>http://www.patentstorm.us/patents/8101777/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101777</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Zhao, Dongbin; Dyson, Paul; Fei, Zhaofu</li></ul>
<p>Novel chemical compounds of the general formula
<br></br>
K<sup>+</sup>A<sup>−</sup>,
<br></br>
in which K<sup>+</sup> is a 5- or 6-membered heterocyclic ring having 1-3 hetereo atoms, which can be independently N, S, or O;
</p>
<p>with the proviso that at least one of the hetereo atoms must be a quaternized nitrogen atom having a —R′CN substituent, wherein R′ is alkyl (C<sub>1 </sub>to C<sub>12</sub>);</p>
<p>the heterocyclic ring having up to 4 or 5 substituents independently ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101777</guid>
			
			      </item>
<item>
			         <title><![CDATA[Organic semiconductors and their manufacture]]></title>
			         <link>http://www.patentstorm.us/patents/8101776/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101776</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Berens, Ulrich; Bienewald, Frank; Kirner, Hans Jürg</li></ul>
<p>The invention relates to a semiconductor device comprising a compound of the formula I and of the formula XXI, wherein the symbols have the meanings defined in the specification, to the novel compounds of the formula I and XXI and to the use of such a compound as an organic semiconductor for the preparation of an electronic device, and further compounds and devices, as well as other embodiments given in the ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101776</guid>
			
			      </item>
<item>
			         <title><![CDATA[Indole derivatives as S1P1 Receptor]]></title>
			         <link>http://www.patentstorm.us/patents/8101775/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8101775</li><li><strong>Publication Date:</strong> &nbsp;2012-01-24</li><li><strong>Inventors:</strong> &nbsp;Norton, David; Ahmed, Mahmood; Myatt, James; Rivers, Dean Andrew</li></ul>
<p>The invention relates to compounds of formula (I)</p>
<p><chemistry>

</chemistry>
<br></br>
wherein
<ul>
    <li>one of R<sub>5 </sub>and R<sub>6 </sub>is hydrogen or R<sub>2 </sub>and the other is (a)</li>
</ul>
</p>
<p><chemistry>

</chemistry>
<br></br>
pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the S1P1 ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8101775</guid>
			
			      </item>
<item>
			         <title><![CDATA[Crystalline sodium atorvastatin]]></title>
			         <link>http://www.patentstorm.us/patents/8097734/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097734</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Liu, Hong; Zhou, Kailan; Chen, Zhirong; Hong, Huabin; Sun, Yang; Wang, Yunde; Pan, Jiangchun</li></ul>
<p>Crystalline sodium atorvastatin, compositions containing the same and methods for the production ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097734</guid>
			
			      </item>
<item>
			         <title><![CDATA[Pyrazole derivatives as 5-LO-inhibitors]]></title>
			         <link>http://www.patentstorm.us/patents/8097733/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097733</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Graneto, Matthew J.; Grapperhaus, Margaret Lanahan; Alvira, Edgardo; Iyanar, Kaliappan; Maddux, Todd Michael; Mahoney, Matthew William; Massa, Mark Alan; Sample, Kirby Ray; Schmidt, Michelle Ann; Seidel, Ronald Edward; Selbo, Jon Gordon; Tollefson, Michael Brent; Vonder Embse, Richard Alan; Wagner, Grace Mary; Woodard, Scott Santford</li></ul>
<p>The invention relates to compounds of formula (I)</p>
<p><chemistry>

</chemistry>
<br></br>
processes for their preparation, their use as 5-lipoxygenase inhibitors and pharmaceutical compositions containing the ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097733</guid>
			
			      </item>
<item>
			         <title><![CDATA[1-arylpyrazoles and their use as pesticide]]></title>
			         <link>http://www.patentstorm.us/patents/8097732/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097732</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Chou, David T.; Petry, Friederike; Maier, Michael; Knauf, Werner</li></ul>
<p>Disclosed are compounds of formula (I) or pesticidally acceptable salts thereof, wherein, for example, W is ═N—, ═CH—, ═CR<sup>7</sup>— or ═C(NR<sup>8</sup>R<sup>9</sup>)—, R<sup>7 </sup>is halogen, R<sup>8 </sup>and R<sup>9 </sup>are independently of one another hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl, aralkyl or heterocyclylalkyl, R<sup>1 </sup>is cyano, halogen, haloalkyl or CS NH<sub>2</sub>, R<sup>2 </sup>is alkyl or cycloalkyl, R<sup>3 ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097732</guid>
			
			      </item>
<item>
			         <title><![CDATA[Reaction products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidalzoles with epoxides as lubricant additives]]></title>
			         <link>http://www.patentstorm.us/patents/8097731/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097731</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Rowland, Robert G.; Abbott, Ronald D.</li></ul>
<p>A composition comprising:
<ul>
    <li>
    <ul>
        <li>(A) a lubricant, and</li>
        <li>(B) at least one alcohol that is the reaction product of mercaptobenzothiazoles, mercaptothiazolines, or mercaptobenzimidazoles with various epoxies.</li>
    </ul>
    ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097731</guid>
			
			      </item>
<item>
			         <title><![CDATA[Bicyclic heterocycles useful as selective androgen receptor modulators]]></title>
			         <link>http://www.patentstorm.us/patents/8097730/description.html</link>
			         <description><![CDATA[<ul><li><strong>Patent Number:</strong> &nbsp;8097730</li><li><strong>Publication Date:</strong> &nbsp;2012-01-17</li><li><strong>Inventors:</strong> &nbsp;Zhang, Xuqing; Sui, Zhihua</li></ul>
<p>The present invention is directed to novel bicyclic heterocycles, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen ...<br /> 		
			         		]]></description>
			         
			         <guid isPermaLink="false">8097730</guid>
			
			      </item>
</channel>
		</rss>
